EUVIMED · CrossrefZeitschrift
Liver Transplantation
ISSN 1527-6465 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Liver perfusion sudoku: Striking a balance between organ utilization, clinical outcomes, and logistics
Living donor–domino liver transplantation for maple syrup urine disease: surgical and metabolic outcomes
Hospital at home for the acute care of patients with liver disease: a clinical review
MELD-Based Allocation and Alcohol-Associated Liver Disease: Evidence of the Same Allocation Paradox in an Organ-Scarce Setting
Letter To The Editor: Hernia incarceration after TIPS: Complication or opportunity for definitive treatment?
Endoscopic management of biliary stricture in primary sclerosing cholangitis
AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Posttransplant management
Can robotic living donor hepatectomy be safely offered to all donors? evidence, experience, and program development
Are we over-immunosuppressing liver transplant recipients?
Letter to the Editor: Day-7 thresholds in a moving target—Separating small-for-size physiology from early allograft dysfunction in LDLT
Letter to the Editor: Who should receive a graft for unresectable colorectal liver metastases? Lessons from real-world TransMet validation for living-donor programs
Reply: Who should receive a graft for unresectable colorectal liver metastases? Lessons from real-world TransMet validation for living-donor programs
A randomized controlled trial of normothermic versus dual-hypothermic oxygenated ex situ perfusion in DCD liver transplantation
Development and internal validation of the Laboratory-based Liver Frailty Index (Lab-LFI)—A prediction model for frailty in patients with cirrhosis
Differences in donation after circulatory determination of death (DCD) liver donor management—An international survey initiated by the International Liver Transplantation Society (ILTS), Society for the Advancement of Transplant Anesthesia (SATA), and Liver Intensive Care Group of Europe (LICAGE)
A tale of two cholangiopathies: Divergence, parity, and paradox
Work–life chaos: Enhancing mental health during times of strife
Letter to the Editor: A more urgent case for building the hybrid living and deceased donor liver transplant pathway
Serum ammonia improves early risk stratification beyond West Haven criteria in acute liver failure
External validation of the SNAPP score for hepatocellular carcinoma recurrence after living donor liver transplantation
Letter to the Editor: Initial outcomes and global demand for liver transplant mentorship—The International Liver Transplantation Society experience
Letter to the Editor: Pretransplant exercise prehabilitation or posttransplant nutritional support for better outcomes in living donor liver transplantation
Letter to the Editor: Peripheral limitation as the main factor for reduced cardiorespiratory fitness and no beta-blocker effects in patients with cirrhosis
Long-term graft and patient survival of patients with portal vein stenosis after pediatric liver transplantation: Results from the multicenter multinational PORTAL registry
Recurrent primary sclerosing cholangitis after liver transplantation: Impact of inflammatory bowel disease on graft outcomes in a Southern European multicenter cohort
Graft-to-recipient weight ratio, graft inflow modulation, and small-for-size syndrome: A multicenter prospective study from the International LDLT registry (LDLTregistry.org).
External validation of the SALT-M score in living donor liver transplantation for acute-on-chronic liver failure
Reply: Prophylactic tranexamic acid in liver transplantation—Looking beyond the primary endpoint
Comparison of MELD, MELD-Na, and MELD 3.0 scoring systems for transplant prioritization in the Turkish population: A multicenter study
Letter to the Editor: Prophylactic tranexamic acid in liver transplantation—Looking beyond the primary endpoint
EUVIMED